Dr. Mark Stibich is a founder and Chief Scientific Officer for Xenex Healthcare Services, a company that uses a patented pulsed xenon disinfection system to make patient care areas safer by reducing the microbial contamination (from “superbugs” such as MRSA, VRE and C. diff.). Xenex has been featured in Forbes, CNN and other media outlets as well as in peer-reviewed scientific publications.
Dr. Stibich specializes in creating efficient solutions for public health problems. He received his doctoral training from the Johns Hopkins School of Public Health and has been involved in multiple international research and intervention projects. He is an inventor on over 80 granted patents and a principal investigator on an NIH grant.
Specialties: infection control, protocol design, UV disinfection, area disinfection, disinfection of public spaces, public health, business development